backBack to Nova Southeastern University
Barry and Judy Silverman
College of Pharmacy

Our Faculty and Staff

  1. Pharmacy
  2. People

Narasimman Gurusamy, M.Pharm, Ph.D.

Narasimman Gurusamy

Title:

Assistant Professor

Department:

Pharmaceutical Sciences

College/Division:

Barry and Judy Silverman College of Pharmacy

Campus:

Fort Lauderdale/Davie

Dr. Narasimman Gurusamy an Assistant Professor in the Department of Pharmaceutical Sciences at the Barry and Judy Silverman College of Pharmacy, Nova Southeastern University. His academic roots trace back to the Tamil Nadu Dr. MGR Medical University and Birla Institute of Technology in India, from where he embarked on his educational journey in the field of Pharmacy. He further enhanced his academic credentials by obtaining a Ph.D. in Pharmaceutical Sciences from Niigata University of Pharmacy and Applied Life Sciences in Japan. Committed to furthering his knowledge, Dr. Gurusamy undertook postdoctoral fellowships across the USA, where he refined his expertise in molecular cardiology and stem cell biology at esteemed institutions such as UConn Health Center, Harvard Medical School, and the University of Tennessee Health Science Center.

In his professional journey, Dr. Gurusamy has significantly contributed to the field of cardiovascular biology, unveiling critical insights into how autophagy is crucial for cardiac protection. His research has also illuminated the pivotal role of the 14-3-3 protein in regulating cardiac cell death and hypertrophy. Recognized for his innovative work, he has been awarded the American Heart Association Career Development Award for his project focused on "Autologous induced-mesenchymal stem cells and their exosomes therapy for myocardial injury". Currently, his research is aimed at uncovering the epigenetic mechanisms that influence the progression and repair of cardiac diseases, with a particular interest in the unique functions of non-coding RNAs. Beyond his research, Dr. Gurusamy contributes to the academic and professional community as a grant reviewer for the American Heart Association, an Associate Editor for Frontiers in Cardiovascular Medicine, and serves as the Vice-Chair for the Communication Committee of Society for South Asian Heart Research (SAHR).

  • Recipient of various research grants including from American Heart Association as principal investigator
  • Published over 60 research articles, 55 scientific abstracts, and 6 book chapters
  • Serves as Grant Reviewer for American Heart Association.
  • Associate Editor for Frontiers in Cardiovascular Medicine
  • Edited a Special Issue in Cells as a Guest Editor
  • Serves as a reviewer for more than 40 journals and Editorial Board member for 5 journals
  • A recipient of the Young Research Scientist Award and several Travel Awards

Dr. Gurusamy’s laboratory employs multidisciplinary approaches to elucidate the role of long non-coding RNAs in the epigenetic regulation of various cardiac diseases and during the intervention-mediated repair.

The team is also investigating the cardioprotective roles of induced mesenchymal stem cells and their exosomes in the protection against ischemic cardiomyopathy.

Furthermore, they are delving into gene-environment interactions by examining how diet and environmental toxins contribute to epigenetic changes that lead to cardiac diseases.

Additionally, the lab is exploring the effectiveness of various interventions, including pharmacological agents, and lifestyle modifications, in altering epigenetic markers and improving outcomes in human diseases.

Research Interests keywords

Epigenetics, Cardiac diseases, non-coding RNA, Exosomes, Stem cells, Autophagy

  • Investigate the role of long non-coding RNAs in the epigenetic regulation of cardiac diseases and repair.
  • Examine the role of induced mesenchymal stem cells and their exosomes in mediating cardioprotection.
  • Analyze the effect of gene-environment interactions, of diet and environmental toxins on the epigenetic alterations in cardiac diseases.
  • Evaluate the effectiveness of pharmacological agents and lifestyle changes on epigenetic markers and disease outcomes.

  • In-vitro (cell culture), In-vivo (animal models) and Clinical Trials Molecular Biological Techniques: PCR, Real-time quantitative PCR, Gel electrophoresis, Western immunoblotting.
  • Cell Biology Techniques: Immunofluorescence, Immunohistochemical assays, ELISA, Flow cytometry, Fluorescence and confocal microscopic analysis.
  • Analysis of Genomic and Epigenomic Repositories including NCBI Gene Expression Omnibus (GEO), Methylation Data Repositories and UCSC Genome Browser.
  • Collaborators in USA and India.

Research opportunities are available for students in the following areas.

  • Elucidating the disease progression and repair mechanisms of cardiovascular diseases
  • Epigenetic regulation by non-coding RNA
  • Treatment with exosomes, stem cells, and pharmaceutical agents
  • Autophagy
  • Epigenetic regulation by environmental factors and human lifestyle in inducing diseases